Acne
Actinic Keratosis
Alcoholism
Alopecia areata
Andropause
Angioma
Aquagenic Pruritus
Asthma
Athlete's Foot
Atopic Dermatitis
Baldness
Baldness Treatments
Basal Cell Carcinoma
Bedsores
Behcet's Disease
Blepharitis
Boils
Bowen's Disease
Bullous Pemphigoid
Canker Sores
Carbuncles
Cellulite
Cellulitis
Cercarial Dermatitis
Cerebral Palsy
Cold Sores
Dandruff
Dermatitis Herpetiformis
Dermatofibroma
Dermatology
Domestic Violence
Dyshidrosis
Emphysema
Erectile Dysfunction
Menopause
Neuropathy
Personal Injury
Seborrhoeic Dermatitis
Spousal Abuse
Tooth Bleaching
Trichotillomania
Urology
Varicose veins
This website provides you with information regarding a large number of common (and not so common) illnesses and their symptoms. Use the navigation on the left of the page to select topics.
Each topic contains detailed information regarding the illness, giving background information, symptoms, associated problems, preventative measures and treatments and cures available.
In The News:
|
Gene Variant For Biological Ageing In Humans Discovered Scientists from the UK and The Netherlands have identified for the first time a variant of a gene that is linked to biological ageing in humans and suggest the discovery will help us better understand cancer and diseases of ageing. The findings of the study by researchers based at the University of Leicester and King's College London, UK, and also at the University of Groningen in the Netherlands, were reported online in Nature Genetics on 7 February. The Wellcome Trust and the British Heart Foundation sponsored the work...
Mon, 08 Feb 2010 11:00:00 PST SciClone And Sigma-Tau Announce Additional Positive Results In Clinical Study Examining ZADAXIN's Ability To Enhance Response To H1N1 Vaccine SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) and its partner Sigma-Tau S.p.A., announced additional topline results in a clinical study evaluating the potential of ZADAXIN® (thymalfasin) to enhance immune response to the MF59 adjuvanted H1N1 influenza monovalent vaccine, Focetria? from Novartis. According to investigators, ZADAXIN treatment given with the H1N1 vaccine led to a statistically significant (p value=0.04) increase in the percentage of subjects who seroconverted, also when evaluated 42 days after vaccination, compared to those who received the H1N1 vaccine alone...
Mon, 08 Feb 2010 05:00:00 PST Don't Let Cupid's Arrows Make Your Eyes Water, With New Guide To Passionate Safer Sex From THT, UK Just in time for Valentine's Day, HIV and sexual health charity Terrence Higgins Trust (THT) is publishing an online guide with top tips on how to use condoms and protect your sexual health without killing the romantic mood. A recent study found 43% of men and 38% of women didn't always use a condom when having sex with a new partner¹. Some argue that safer sex and romance just don't mix, with worries that condoms are uncomfortable, ruin the sensation, or even interrupt those tried and tested seduction techniques...
Mon, 08 Feb 2010 05:00:00 PST Teva Announces Settlement In Principle Regarding Certain Drug Pricing Lawsuits Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced that several of its subsidiaries in the United States reached a settlement in principle to resolve claims brought by Ven-A-Care of the Florida Keys, Inc. on behalf of the United States, Texas, Florida, and California under federal and state False Claims Acts. Together with many other pharmaceutical manufacturers, Teva is named in numerous civil lawsuits that relate to drug price reporting by manufacturers in about 15 states...
Mon, 08 Feb 2010 04:00:00 PST More Than $119 Million Awarded To States And Territories The U.S. Department of Health and Human Services (HHS) awarded more than $119 million to states and U.S. territories to support public health efforts to reduce obesity, increase physical activity, improve nutrition, and decrease smoking-the four most important actions for combating chronic diseases and promoting health. This money supports the one of several components in the Department's comprehensive prevention and wellness initiative, Communities Putting Prevention to Work, which is funded under the American Recovery and Reinvestment Act of 2009...
Mon, 08 Feb 2010 04:00:00 PST BIO Joins Stakeholders In Expressing Concerns With Efforts To Restrict Gene Patenting The Biotechnology Industry Organization (BIO) released a letter to Health and Human Services Secretary Kathleen Sebelius regarding the potentially harmful recommendations of the Secretary's Advisory Committee on Genetics, Health and Society (SACGHS) in its Report on Gene Patents and Licensing Practices and Their Impact on Patient Access to Genetic Tests...
Mon, 08 Feb 2010 04:00:00 PST Chief Medical Officer Mobilises GPs To Support Pandemic (H1N1) 2009 Influenza Vaccinations Australia's Chief Medical Officer, Professor Jim Bishop, is calling on GPs to promote vaccination against the pandemic (H1N1) 2009 influenza to their patients before the flu season begins in Australia . Professor Bishop has enlisted the support of his GP Roundtable, which includes representatives of the AMA, RACGP and the GP Network and he is writing to all GPs in Australia to ask them to proactively promote vaccination for all people aged 6 months and above in an effort to stop the spread of swine flu which is expected to be the dominant influenza strain in 2010...
Mon, 08 Feb 2010 04:00:00 PST Gaining Market Access By Providing Value For Money Cost-effectiveness research will become more important as EU responsibility for the pharmaceutical sector moves to the Health and Consumer policy directorate, Lynne Taylor and Peter Mansell report. Consumer advocates and industry critics have welcomed the new European Commission's decision to switch responsibility for the pharmaceutical sector from DG Enterprise and Industry to the Health and Consumer policy directorate, DG Sanco. Critics have long claimed that pharmaceutical policy, as an integral part of public health policymaking, should be driven by medicines access and safety issues...
Mon, 08 Feb 2010 04:00:00 PST Siemens Showcases New Dedicated Women's Imaging Ultrasound Platforms At SMFM Featuring the new release of its premium ACUSON S2000? ultrasound system - Women's Imaging and ACUSON X300? ultrasound system, premium edition (PE) - Women's Imaging, Siemens Healthcare (booth #813) will highlight the latest innovations in OB/GYN imaging at the Society for Maternal-Fetal Medicine's (SMFM) 30th Annual Meeting in Chicago. Siemens will be showcasing advanced clinical applications that bring a new dimension of diagnosis and workflow enhancements to fetal ultrasound...
Mon, 08 Feb 2010 04:00:00 PST Siemens Healthcare WebShop Now Available For Ultrasound Products Siemens Healthcare announces a one-stop shop for ultrasound application upgrades and options, now available through Siemens Healthcare's webShop at http://www.usa.siemens.com/webshop. By providing ultrasound users with the opportunity to browse through and sample new applications for their Siemens ultrasound imaging equipment, webShop offers a smart and easy way to discover the clinical benefits of the latest ultrasound applications...
Mon, 08 Feb 2010 04:00:00 PST |